Skip to Main Content

Author Details

Raymond J Pickles
Marsico Lung Institute, University of North Carolina-Chapel Hill
1991
93
47
PMIDPaper TitleJournal TitlePublished Year
36965846Modeling identifies variability in SARS-CoV-2 uptake and eclipse phase by infected cells as principal drivers of extreme variability in nasal viral load in the 48 h post infection.J Theor Biol2023
37159271Human T cells efficiently control RSV infection.JCI Insight2023
35040594Pharmacokinetic-based failure of a detergent virucidal for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) nasal infections: A preclinical study and randomized controlled trial.Int Forum Allergy Rhinol2022
35378080Modeling insights into SARS-CoV-2 respiratory tract infections prior to immune protection.Biophys J2022
35074895Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein.Proc Natl Acad Sci U S A2022
33276017Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19.J Control Release2021
33561864SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.Nature2021
34013253Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections.Res Sq2021
33309815Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy.Adv Drug Deliv Rev2021
32995766Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801.Res Sq2020
31451733Precision mouse models with expanded tropism for human pathogens.Nat Biotechnol2019
26976607SARS-like WIV1-CoV poised for human emergence.Proc Natl Acad Sci U S A2016
28000669A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.Nat Commun2016
27279612A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats.J Virol2016
25302625Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis.J Pathol2015
24475177Effects of vitamin D on airway epithelial cell morphology and rhinovirus replication.PLoS One2014
24713657RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction.J Clin Invest2014
22929560Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways.Mucosal Immunol2013
24362700Human airway epithelial cell cultures for modeling respiratory syncytial virus infection.Curr Top Microbiol Immunol2013
23365422Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells.J Virol2013
23012413Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs.Proc Natl Acad Sci U S A2012
22959894Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium.Virology2012
20935191Coupled nucleotide and mucin hypersecretion from goblet-cell metaplastic human airway epithelium.Am J Respir Cell Mol Biol2011
21998692A single amino acid in the HA of pH1N1 2009 influenza virus affects cell tropism in human airway epithelium, but not transmission in ferrets.PLoS One2011
21986028Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus.Virology2011
22164298Yeast based small molecule screen for inhibitors of SARS-CoV.PLoS One2011
21816184Limited effects of Muc1 deficiency on mouse adenovirus type 1 respiratory infection.Virus Res2011
21625534AAV exploits subcellular stress associated with inflammation, endoplasmic reticulum expansion, and misfolded proteins in models of cystic fibrosis.PLoS Pathog2011
21703540NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways.Immunity2011
21752418AAV-6 mediated efficient transduction of mouse lower airways.Virology2011
21508186Lack of transmission of a human influenza virus with avian receptor specificity between ferrets is not due to decreased virus shedding but rather a lower infectivity in vivo.J Gen Virol2011
21106732Receptor binding profiles of avian influenza virus hemagglutinin subtypes on human cells as a predictor of pandemic potential.J Virol2011
19969320Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.Virology2010
20735256α-Fetoprotein gene delivery to the nasal epithelium of nonhuman primates by human parainfluenza viral vectors.Hum Gene Ther2010
20719951Culturing the unculturable: human coronavirus HKU1 infects, replicates, and produces progeny virions in human ciliated airway epithelial cell cultures.J Virol2010
20504917Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.J Virol2010
20139088Selective translocation of the Bordetella pertussis adenylate cyclase toxin across the basolateral membranes of polarized epithelial cells.J Biol Chem2010
20139039Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys.Vaccine2010
20331639Infection of human mucosal tissue by Pseudomonas aeruginosa requires sequential and mutually dependent virulence factors and a novel pilus-associated adhesin.Cell Microbiol2010
19010509Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge.Virology2009
19924306Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium.PLoS One2009
19656891Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans.J Virol2009
19621064CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.PLoS Biol2009
19603002Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium.Mol Ther2009
19436701Avian Influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways.PLoS Pathog2009
19404494MAVS-mediated apoptosis and its inhibition by viral proteins.PLoS One2009
19362020The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.Immunity2009
19066597Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro.Mol Ther2009
19190083Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense.FASEB J2009
18931053Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways?Am J Physiol Lung Cell Mol Physiol2009
  • 1 - 50 of 93

Recommended Authors

Center for Immunity and Immunotherapies, Seattle Children's Research Institute
Career Start Year 2018
Number of shared co-authors 0
Gladstone Institute of Virology
Career Start Year 2015
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Institute of Medical Virology, University of Zurich
Career Start Year 2012
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR 9
Career Start Year 2012
Number of shared co-authors 0
University of California berkeley
Career Start Year 2011
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 15
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
University of Washington School of Medicine, Seattle Benaroya Research Institute
Career Start Year 2007
Number of shared co-authors 1
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 4
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 15
University of Iowa
Career Start Year 2002
Number of shared co-authors 2
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 3
The University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 1
Boston Children's Hospital, Harvard Medical School
Career Start Year 2000
Number of shared co-authors 0
University of Rochester Medical Center
Career Start Year 1999
Number of shared co-authors 2
University of Pittsburgh
Career Start Year 1999
Number of shared co-authors 0
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 0
College of Medicine, University of Nebraska Medical Center
Career Start Year 1997
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Seattle Children's Hospital, University of Washington
Career Start Year 1996
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 3
Merck & Co., Inc.
Career Start Year 1989
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 1986
Number of shared co-authors 1
Nottingham NIHR Biomedical Research Centre
Career Start Year 1986
Number of shared co-authors 0
University of Virginia School of Medicine
Career Start Year 1981
Number of shared co-authors 1
Dartmouth College
Career Start Year 1979
Number of shared co-authors 0
Carver College of Medicine, University of Iowa
Career Start Year 1978
Number of shared co-authors 0

Collaborators

Co-authored papers 20
University of North Carolina
Co-authored papers 18
The University of North Carolina at Chapel Hill
Co-authored papers 11
Co-authored papers 7
Co-authored papers 6
University of North Carolina at Chapel Hill
Co-authored papers 6
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
University of North Carolina at Chapel Hill
Co-authored papers 4
Co-authored papers 3
University of North Carolina at Chapel Hill
Co-authored papers 3
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 2
Co-authored papers 2
University of Texas Medical Branch
Co-authored papers 2
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 2
University of North Carolina
Co-authored papers 2
12328Vanderbilt University Medical Center
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 2
Co-authored papers 2
University of North Carolina at Chapel Hill.
Co-authored papers 2
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 1
The University of Texas Medical Branch
Co-authored papers 1
Co-authored papers 1
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 1
University of Wisconsin School of Medicine and Public Health
Co-authored papers 1